HALOZYME THERAPEUTICS INC

CUSIP: 40637HAF6 Class: NOTE 1.000% 8/1

Boussard & Gavaudan Investment Management LLP's Holding History (CIK: 0001614986)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 2,100 Value ($000) $2,968 Avg Close — Range —
Q2 2024
Shares 7,000 Value ($000) $7,776 Avg Close — Range —